We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Compromised immunity

17 January 2019 By John Foley

James Gorman’s bank did worse than rivals last quarter, delivering only a 7.1 pct annualized ROE. Fixed-income revenue slumped and lending losses made things worse. Morgan Stanley’s valuation premium is partly because it’s supposed to be more stable. That logic just took a knock.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)